Protalix BioTherapeutics, Inc. PLX
2.69 USD +0.08 (+3.07%)
At closeNov 5, 2026, 4:29 AM EST
2.51 -0.18 -6.69%
Pre-market · Nov 5, 4:29 AM ET
2.63 Day range 2.73
1.65 52-week range 3.19
- YTD
- +49.44%
- 1 year
- +13.03%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 52.74M | 53.40M | 65.49M | 47.64M | 38.35M | |
| 25.75M | 29.08M | 42.51M | 28.05M | 22.00M | |
| -5.50M | 3.92M | 10.46M | -13.01M | -20.46M | |
| -6.60M | 2.93M | 8.31M | -14.93M | -27.58M | |
| -0.08 | 0.04 | 0.09 | -0.31 | -0.62 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 15.38M | 19.76M | 23.63M | 17.11M | 38.98M | |
| 82.35M | 73.42M | 84.43M | 55.79M | 73.67M | |
| 34.12M | 30.21M | 50.87M | 66.43M | 79.70M | |
| 8.32M | 5.53M | 26.28M | 33.47M | 33.47M | |
| 48.23M | 43.21M | 33.57M | -10.64M | -6.04M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -11.99M | 8.67M | -1.32M | -25.00M | -10.29M | |
| -2.37M | 4.22M | -16.71M | -5.04M | 18.92M | |
| 9.33M | -16.79M | 24.67M | 8.24M | 12.08M | |
| -1.64M | -1.28M | -1.15M | -628.00K | -1.41M | |
| -5.08M | -3.87M | 6.52M | -21.87M | 20.72M |